A possibly overlooked side effect of Orlistat: gastroesophageal reflux disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the National Medical Association

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0027-9684(15)31487-5PMID 18942283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity increases oesophageal acid exposure

  2006cited by this paper
• Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

  1998cited by this paper

• Phytochemical Analysis of Triphala Extract, In Vitro and In Silico Evaluation of Pancreatic Lipase Inhibition for Obesity Management

  2025cites this paper
• Advanced multifunctional nano-delivery platform focusing on treating diseases related to lipid metabolism via targeted intervention in various lipid metabolic processes

  2025cites this paper
• Lipidomic Analysis Reveals the Anti-Obesity and Hepatoprotective Effects of Flavonoid Mimetic Components in Adzuki Beans on High-Fat Diet-Induced Obese Mice

  2025cites this paper
• A computational study to probe the binding aspects of potent polyphenolic inhibitors of pancreatic lipase

  2023cites this paper
• Assessing Anti-Adipogenic Effects of Mango Leaf Tea and Mangiferin within Cultured Adipocytes

  2023cites this paper
• Ribes fasciculatum Ameliorates High-Fat-Diet-Induced Obesity by Elevating Peripheral Thermogenic Signaling

  2022cites this paper
• Cichoriin, a Biocoumarin, Mitigates Oxidative Stress and Associated Adverse Dysfunctions on High-Fat Diet-Induced Obesity in Rats

  2022cites this paper
• Central Administration of Sargahydroquinoic Acid Elevates Peripheral Thermogenic Signaling and Ameliorates High Fat Diet-Induced Obesity

  2021cites this paper
• Protective effect of grape seed extract and orlistat co-treatment against stroke: Effect on oxidative stress and energy failure.

  2021cites this paper
• Hypothalamic administration of sargahydroquinoic acid elevates peripheral thermogenic signaling and ameliorates high fat diet-induced obesity through the sympathetic nervous system

  2021cites this paper
• Antioxidative and digestive enzymes inhibitory activities of 27 edible plants

  2021cites this paper
• Hypothalamic administration of sargahydroquinoic acid elevates peripheral thermogenic signaling and ameliorates high fat diet-induced obesity through the sympathetic nervous system

  2021cites this paper
• Sargahydroquinoic acid, a major compound in Sargassum serratifolium (C. Agardh) C. Agardh, widely activates lipid catabolic pathways, contributing to the formation of beige-like adipocytes

  2019cites this paper
• The ameliorative effect of Protaetia brevitarsis Larvae in HFD-induced obese mice

  2019cites this paper
• Enzyme-treated Ecklonia cava extract inhibits adipogenesis through the downregulation of C/EBPα in 3T3-L1 adipocytes

  2017cites this paper
• Anti-obesity effects of pectinase and cellulase enzyme-treated Ecklonia cava extract in high-fat diet-fed C57BL/6N mice

  2017cites this paper
• Natural Products with Anti-obesity Effects and Different Mechanisms of Action.

  2016cites this paper
• Traditional Herbal Formula Oyaksungi-San Inhibits Adipogenesis in 3T3-L1 Adipocytes

  2015cites this paper
• Traditional Korean Herbal Formula Samsoeum Attenuates Adipogenesis by Regulating the Phosphorylation of ERK1/2 in 3T3-L1 Cells

  2015cites this paper
• Anti-adipogenic and antioxidant effects of the traditional Korean herbal formula Samchulgeonbi-tang: an in vitro study.

  2015cites this paper
• Benefit-Risk Assessment of Orlistat in the Treatment of Obesity

  2014cites this paper
• Benefit-Risk Assessment Ofof Orlistat In Thein the Treatment Ofof Obesity

  2014cites this paper
• Effects of Yeoldahanso-tang, a Sasang Constitutional Herbal Prescription for Taeeumin, on the Adipogenesis in 3T3-L1 Cells

  2012cites this paper
• Orlistat: current status in clinical therapeutics

  2009cites this paper